Danish biotech company to invest 4.5 billion kroner in Indian factory

Novonesis is putting 600 million euros into an expansion of its production facilities in Patalganga, central India. The investment, worth about 4.5 billion Danish kroner, is intended to create one of the world’s most advanced enzyme factories.

The facilities are expected to become fully operational in 2030. Chief Executive Ester Baiget described the project as an important part of the company’s strategy and linked it to continued investment in sustainable growth.

“

This is an important step in implementing our strategy and reflects our continued focus on investing in sustainable growth.

“This is an important step in implementing our strategy and reflects our continued focus on investing in sustainable growth,” Baiget said in a company statement. She added that the expansion would strengthen Novonesis’ ability to support customers worldwide and create long-term value for shareholders.

Novonesis was created through the merger of Chr. Hansen and Novozymes, completed at the beginning of 2024. The company produces ingredients used in detergents and foods including milk, yogurt and cheese. It also makes biofuels.

“

The expansion strengthens our ability to support customers around the world and enables us to continue creating long-term value for our shareholders.